Official launch for the new cervical Ti cage TRYPTIK® Ti

After a successful limited release period and more than 2000 implanted cages worldwide, Spineart is proud to announce the official full launch of TRYPTIK®Ti, the first cervical Ti-LIFE cage.

The Ti-LIFE range of cages is now complete enabling any surgical interbody approach from the cervical to the lumbar spine.

More information about the product here and on Ti-LIFE Technology.

Related items
Date - Category	Title	Excerpt
11.11.2026 Corporate	SPINEART SUPPORTED A CAMBODIA OUTREACH TRIP – CHILDREN’S SURGICAL CENTRE, PHNOM PENH	For the fifth consecutive year, Spineart is proud to support our ANZ distributor, Life Healthcare, in its charitable mission to Cambodia. Spineart provides all the implants and instruments required...
26.08.2026 Innovation	Spineart and eCential Robotics receive FDA 510(k) clearance for the PERLA® TL application for use with eCential® Op.n® navigation system for robotic procedures.	Geneva, Switzerland, August 26, 2026 – Spineart, a global fast-growing company in spine surgery innovation, and eCential Robotics today announced that the U.S. Food and Drug Administration (FDA) has granted...
11.08.2026 BAGUERA® C	Spineart Announces FDA Approval of BAGUERA® C Cervical Disc	Spineart announces that the BAGUERA® C cervical disc has received FDA approval for 1 and 2 contiguous levels, expanding access in the United States to a motion-preserving solution for patients suffering from...

Related items

Date - Category

Illustration

Title

Excerpt

11.11.2026

Corporate

SPINEART SUPPORTED A CAMBODIA OUTREACH TRIP – CHILDREN’S SURGICAL CENTRE, PHNOM PENH

For the fifth consecutive year, Spineart is proud to support our ANZ distributor, Life Healthcare, in its charitable mission to Cambodia. Spineart provides all the implants and instruments required...

26.08.2026

Innovation

Spineart and eCential Robotics receive FDA 510(k) clearance for the PERLA® TL application for use with eCential® Op.n® navigation system for robotic procedures.

Geneva, Switzerland, August 26, 2026 – Spineart, a global fast-growing company in spine surgery innovation, and eCential Robotics today announced that the U.S. Food and Drug Administration (FDA) has granted...

11.08.2026

BAGUERA® C

Spineart Announces FDA Approval of BAGUERA® C Cervical Disc

Spineart announces that the BAGUERA® C cervical disc has received FDA approval for 1 and 2 contiguous levels, expanding access in the United States to a motion-preserving solution for patients suffering from...